. In this study, the in vitro activity of Sch 21420 against both gentamicin-resistant and gentamicin-susceptible Gram-negative bacilli was compared with that of gentamicin, tobramycin, sisomicin, netilmicin and amikacin.
All Gram-negative bacilli used in this study were isolated from clinical materials. The gentamicin-resistant (MIC> 4 ug/ml) strains consisted of Pseudomonas aeruginosa (17 strains), Pseudomonas species (10 strains), Klebsiella species (7 strains), Serratia species (6 strains), Enterobacter species (6 strains), Proteus species (9 strains), Providencia species (14 strains) and Escherichia coli (6 strains). Also tested were 41 strains of gentamicin-susceptible (MIC<4,ug/ml) Enterobacteriaceae which included Klebsiella species (8 strains), Serratia species (9 strains), Enterobacter species (9 strains), Proteus species (5 strains), Providencia species (1 strain) and E. coli (9 strains).
The MIC of Sch 21420, gentamicin, tobramycin, sisomicin, netilmicin, and amikacin was determined simultaneously by the WHO-ICS agar dilution method". MUELLER-HINTON agar Table 1 delivered by a STEERS replicator3). For a given isolate, the same inoculum was used to inoculate all 6 series of agar plates incorporated with serial two-fold dilutions of antibiotics from 64 to 0.25 pg/ml. An agar plate with no antibiotic served as a control.
Plates were incubated at 37°C for 24 hours.
The MIC was defined as the lowest concentration of antibiotic allowing no growth or growth of only one colony. Table 1 shows the comparative in vitro activity of all 6 aminoglycosides against gentamicinresistant Pseudomonas (27 strains) and Enterobacteriaceae (48 strains).
For Pseudomonas, the most active compound was tobramycin. However, Sch 21420 as well as amikacin and sisomicin were effective against a large number of gentamicin-resistant Pseudomonas. Netilmicin was the least active compound.
As for gentamicin-resistant Enterobacteriaceae, Sch 21420
and amikacin had similar activity and were the most active compounds.
Sisomicin and netilmicin were also effective against some gentamicin-resistant organisms, but cross-resistance between gentamicin and tobramycin was complete.
Results of the 41 strains of gentamicin-susceptible Enterobacteriaccae are shown in Table  2 . Sisomicin was the most active compound.
Tobramycin and netilmicin were not as active as gentamicin.
On the weight basis, Sch 21420 was similar to amikacin but there were more strains susceptible to low concentration of Sch 21420 than amikacin.
The results of this investigation indicated that the activity of Sch 21420 was similar to that of amikacin and that Sch 21420 was active against large numbers of gentamicin-resistant Pseudoinonas and Enterobacteriaceae. For gentamicinsusceptible Enterobacteriaceae, Sch 21420 had no advantage over gentamicin.
